The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation
Neurogastroenterology & Motility · 2023-07 · 35 (7)
DOI: 10.1111/nmo.14573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 24.04.2023. Verfasst von Daniel F Castillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Microbiota. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Irritable bowel syndrome (IBS), a disorder of the gut–brain axis, is affected by the microbiome. Microbial studies in pediatric IBS, especially for centrally mediated treatments, are lacking. We compared the microbiome between pediatric IBS patients and healthy controls (HC), in relation to symptom severity, and with percutaneous electrical nerve field stimulation (PENFS), a non‐invasive treatment targeting central pain pathways.
Methods
We collected a stool sample, questionnaires and a 1–2 week stool and pain diary from 11 to 18 years patients with IBS. A patient subset completed 4 weeks of PENFS and repeated data collection immediately after and/or 3 months after treatment. Stool samples were collected from HC. Samples underwent metagenomic sequencing to evaluate diversity, composition, and abundance of species and MetaCyc pathways. Key Results We included 27 cases (15.4 ± 2.5 year) and 34 HC (14.2 ± 2.9 year). Twelve species including Firmicutes spp., and carbohydrate degradation/long‐chain fatty acid (LCFA) synthesis pathways, were increased in IBS but not statistically significantly associated with symptom severity. Seventeen participants (female) who completed PENFS showed improvements in pain ( p = 0.012), disability ( p = 0.007), and catastrophizing ( p = 0.003). Carbohydrate degradation and LCFA synthesis pathways decreased post‐treatment and at follow‐up (FDR p ‐value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Infectious Disease, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: Daniel F Castillo
Förderung
- NIDDK NIH HHS
Zitieren
APA
Castillo, D. F., Denson, L. A., Haslam, D. B., Hommel, K. A., Ollberding, N. J., Sahay, R., & Santucci, N. R. (2023). The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation. Neurogastroenterology & Motility, 35(7). https://doi.org/10.1111/nmo.14573
Vancouver
Castillo DF, Denson LA, Haslam DB, Hommel KA, Ollberding NJ, Sahay R, et al. The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation. Neurogastroenterology & Motility. 2023;35(7). doi:10.1111/nmo.14573
BibTeX
@article{Castillo2023,
author = {Castillo, Daniel F and Denson, Lee A and Haslam, David B and Hommel, Kevin A and Ollberding, Nicholas J and Sahay, Rashmi and Santucci, Neha R},
title = {The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation},
journal = {Neurogastroenterology & Motility},
year = {2023},
volume = {35},
number = {7},
doi = {10.1111/nmo.14573}
}
EUVIMED